SpringWorks Therapeutics Inc (SWTX)
45.84
+1.64
(+3.71%)
USD |
NASDAQ |
Apr 26, 10:19
SpringWorks Therapeutics Shareholders Equity (Quarterly): 626.22M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 626.22M |
| September 30, 2023 | 394.90M |
| June 30, 2023 | 451.44M |
| March 31, 2023 | 506.92M |
| December 31, 2022 | 558.19M |
| September 30, 2022 | 612.40M |
| June 30, 2022 | 325.73M |
| March 31, 2022 | 376.80M |
| December 31, 2021 | 422.40M |
| September 30, 2021 | 466.68M |
| Date | Value |
|---|---|
| June 30, 2021 | 496.58M |
| March 31, 2021 | 534.70M |
| December 31, 2020 | 557.06M |
| September 30, 2020 | 272.76M |
| June 30, 2020 | 290.87M |
| March 31, 2020 | 308.13M |
| December 31, 2019 | 322.07M |
| September 30, 2019 | 337.32M |
| June 30, 2019 | 183.63M |
| December 31, 2018 | -19.37M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
183.63M
Minimum
Jun 2019
626.22M
Maximum
Dec 2023
423.41M
Average
422.40M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Syndax Pharmaceuticals Inc | 554.20M |
| Alnylam Pharmaceuticals Inc | -220.64M |
| Geron Corp | 247.95M |
| Ionis Pharmaceuticals Inc | 386.69M |
| Madrigal Pharmaceuticals Inc | 405.33M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 725.79M |
| Total Liabilities (Quarterly) | 99.57M |
| Current Ratio | 6.408 |